SCHEMBL6003142

SCHEMBL6003142

CCCCCC(Br)(C(=O)O)C(Br)(CCCCC)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.42
CES2 O00748 1/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 6/20 0.41
PPARD Q03181 6/20 0.41
PPARA Q07869 6/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
ALDH1A1 P00352 2/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
PTPN1 P18031 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX15 P16050 1/20 0.41
PDE4A P27815 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001993 0.98 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL6003058 0.93 AKR1B1 (0.39) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL6003249 0.82 FFAR3 (0.35) TSHRALDH1A1MEN1KMT2AHSD17B10
SCHEMBL5075420 0.81 AKR1B1 (0.42) AKR1B1CES2GPR84PPARGPPARD
SCHEMBL16860500 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL22264627 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL10736732 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL22264633 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL11817654 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL29196171 0.79 CES2 (0.45) CES2GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL AKR1B1 237/4885CES2 449/4885GPR84 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.